Status:
COMPLETED
Effect of Rotablator on Balloon Resistant Calcified Coronary Lesion
Lead Sponsor:
Capital Medical University
Collaborating Sponsors:
Beijing Anzhen Hospital
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The optimal treatment of calcified coronary lesion remained to be elucidated. A Prospective, randomized controlled trial was perform to explore the immediate effect and long-term outcome of rotational...
Detailed Description
The inclusion criteria included patients presenting drug-resistant angina pectoris who underwent balloon resistant angioplasty. The exclusion criteria included: 1. Acute myocardial infarction within...
Eligibility Criteria
Inclusion
- Drug-resistant angina pectoris
- Balloon resistant and angiographic calcified coronary lesion
Exclusion
- Acute myocardial infarction within 28 days;
- Intolerance to aspirin, clopidogrel, contrast media, or statins;
- Angiographic visible thrombus, dissection;
- LVEF \<35%;
- Any type of cancer;
- Hemorrhagic stroke
Key Trial Info
Start Date :
January 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2013
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT01887704
Start Date
January 1 2010
End Date
May 1 2013
Last Update
June 27 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Xinguo Wang
Beijing, Beijing Municipality, China, 100029